News
New Associate Medical Directors, Dermatocor (11/14/2008)
Drs. Marta Torres-Quiñones and Matthew Muenster Bolster Veteran Dermatopathology Team
New Medical Director, Gastrocor (10/27/2008)
Bostwick Laboratories announces the appointment of Dr. Steven Lawhorn, M.D.
Bostwick Therapeutics Announces Initiation of Novel Phase I/II Personalized Medicine Immunotherapy Trial for Advanced Prostate Cancer (9/5/2008)
CEO Named Ernst And Young Entrepreneur of the Year (6/20/2008)
Award recognizes Dr. Bostwick’s entrepreneurial excellence in healthcare industry
New Associate Medical Director, Gastrocor (3/23/2008)
Gastrocor™ Announces Appointment of Barbara A. Russo, M.D., as Associate Medical Director, Uniondale, New York
New Medical Director, Dermatocor (3/21/2008)
Bostwick Laboratories® announces the appointment of Dr. Evan Farmer, M.D., as Medical Director of Dermatocor™
Bostwick Laboratories Announces New Laboratory in Nashville, TN (3/20/2008)
Bostwick Laboratories® is pleased to announce the opening of its latest medical laboratory in Nashville, TN.
Bostwick Laboratories Announces Initial Public Offering (3/10/2008)
Bostwick Laboratories, Inc. today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission.
New Associate Medical Director, Gastrocor (1/7/2008)
Bostwick Laboratories® announces the appointment of Dr. Jing Liu, M.D., as Associate Medical Director of Gastrocor™ in its Uniondale, New York laboratory.
New Medical Director (8/7/2007)
Bostwick Laboratories® announces the appointment of Dr. Vito Santarsieri, M.D., as Medical Director of Gastrocor™ based in Uniondale, New York.
Expansion of Medical Lab Services (7/3/2007)
Governor Kaine announces 600 jobs for Henrico-based Bostwick Laboratories to expand its medical lab services
New Laboratory (2/19/2007)
Bostwick Laboratories opens new laboratory in Uniondale, N.Y.,
New Medical Director (2/17/2007)
Bostwick Laboratories announces Dr. Hillel Kahane, M.D. as Medical Director
Introducing PCA3Plus™, the next generation of uPM3™ (5/4/2006)
Bostwick Laboratories, Inc. announces the immediate availability of PCA3PlusTM, a urine-based genetic test for prostate cancer risk, exclusively from Bostwick Laboratories, Inc.
New Selenium Test (4/12/2006)
Selenium levels may predict the risk of a man’s prostate cancer, but there was no simple, reliable selenium test - until now.
VMFA Business Council Creativity Business Award (5/5/2005)
The VMFA Business Council has honored nine Central Virginia firms with its first annual Creativity in Business Awards.
Library Journal Honors American Cancer Society’s (5/3/2005)
Complete Guide to Prostate Cancer, Edited by David G. Bostwick, M.D., MBA
#1 in Prostate Biopsies (3/31/2005)
Bostwick Laboratories performs more prostate biopsies than any other lab -- anywhere. Such disciplined focus could well revolutionize the $35 billion-a-year medical lab business.
New Laboratory (2/7/2005)
Bostwick Laboratories, Inc. opens first international laboratory in London.
Richmond Area’s Fastest-Growing Company (1/27/2005)
Bostwick Laboratories, Inc., has been named the fastest-growing company in the Richmond area for 2004 at an awards ceremony held Thursday night at the Richmond Marriott.